Intracerebral haemorrhage in patients with brain metastases receiving therapeutic anticoagulation
暂无分享,去创建一个
P. Catalano | M. Mendu | B. Alexander | D. Haas-Kogan | J. Connors | S. Tanguturi | A. Aizer | N. Lamba | Mallika L Mendu | D. Cagney | L. Hsu | E. Mehanna | P. Wood | Giovanni P Boyer
[1] G. Lyman,et al. Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D). , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Lynette M. Smith,et al. Safety of long-term anticoagulation in patients with brain metastases , 2018, Medical Oncology.
[3] G. Raskob,et al. Edoxaban for the Treatment of Cancer‐Associated Venous Thromboembolism , 2017, The New England journal of medicine.
[4] S. Bent,et al. Anticoagulation for the treatment of venous thromboembolism in patients with brain metastases: a meta-analysis and systematic review , 2017, Journal of Thrombosis and Thrombolysis.
[5] J. Zwicker,et al. A meta‐analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation , 2016, Journal of thrombosis and haemostasis : JTH.
[6] Catch Investigators. Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: A randomized clinical trial , 2015 .
[7] D. Neuberg,et al. Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study. , 2015, Blood.
[8] C. Flowers,et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Lara A. Kahale,et al. Parenteral anticoagulation in ambulatory patients with cancer. , 2014, The Cochrane database of systematic reviews.
[10] A. Khorana,et al. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer , 2013, Journal of thrombosis and haemostasis : JTH.
[11] S. Patel,et al. Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases , 2012, Melanoma research.
[12] S. Goldhaber,et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. , 2009, The New England journal of medicine.
[13] G. Raskob,et al. Treatment of venous thromboembolism in patients with cancer: Subgroup analysis of the Matisse clinical trials , 2009, Thrombosis and Haemostasis.
[14] Jawed Fareed,et al. Secondary Prevention of Venous Thromboembolic Events in Patients With Active Cancer: Enoxaparin Alone Versus Initial Enoxaparin Followed by Warfarin for a 180-Day Period , 2006, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[15] D. Gerber,et al. Management of venous thromboembolism in patients with primary and metastatic brain tumors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] G. Wells,et al. A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism. , 2005, Archives of internal medicine.
[17] S. Schulman,et al. Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran. , 2003, The New England journal of medicine.
[18] M. Prins,et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. , 2003, The New England journal of medicine.
[19] Yves Gruel,et al. Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study. , 2002, Archives of internal medicine.
[20] W M O'Fallon,et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. , 2000, Archives of internal medicine.
[21] P. Kehrli,et al. [Epidemiology of brain metastases]. , 1999, Neuro-Chirurgie.
[22] L. Deangelis,et al. Therapy of venous thromboembolism in patients with brain metastases , 1994, Cancer.
[23] J. Olin,et al. Treatment of Deep Vein Thrombosis and Pulmonary Emboli in Patients With Primary and Metastatic Brain Tumors Anticoagulants or Inferior Vena Cava Filter , 1987 .
[24] K. Takakura,et al. Spontaneous intracranial hemorrhage caused by brain tumor: its incidence and clinical significance. , 1982, Neurosurgery.